Table 3.
 Cumulative incidence of recurrent venous thromboembolism (VTE) in all patients according to sex and hormonal therapy status
| Time after anticoagulation stopped | Cumulative incidence of recurrent VTE: events per patient year of follow-up (95% CI) | ||||
|---|---|---|---|---|---|
| All men | All women | Men with unprovoked VTE | Women with unprovoked VTE (including women with previous hormone associated VTE) | Women with unprovoked VTE (excluding women with previous hormone associated VTE) | |
| 1 year | 9.5 (7.9 to 11.4) | 5.3 (4.1 to 6.7) | 10.4 (8.6 to 12.8) | 5.6 (4.3 to 7.3) | 6.7 (4.9 to 9.2) |
| 2 years | 14.1 (11.9 to 16.6) | 7.9 (6.4 to 9.8) | 15.8 (13.2 to 18.8) | 8.3 (6.6 to 10.5) | 10.6 (8.1 to 13.8) |
| 3 years | 19.7 (16.5 to 23.4) | 9.1 (7.3 to 11.3) | 22.5 (18.8 to 27.0) | 9.1 (7.2 to 11.6) | 10.6 (8.1 to 13.8) |
| 5 years | 36.3 (28.7 to 45.9) | 11.1 (8.6 to 14.4) | 43.1 (33.8 to 55.1) | 11.5 (8.7 to 15.2) | 12.2 (9.3 to 16.2) |